These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 23353984)
1. Lysophosphatidic acid mediates the release of cytokines and chemokines by human fibroblasts treated with loxosceles spider venom. Horta CC; Oliveira-Mendes BB; do Carmo AO; Siqueira FF; Barroca TM; dos Santos Nassif Lacerda SM; de Almeida Campos PH; de França LR; Ferreira RL; Kalapothakis E J Invest Dermatol; 2013 Jun; 133(6):1682-5. PubMed ID: 23353984 [No Abstract] [Full Text] [Related]
2. Brown recluse spider (Loxosceles reclusa) envenomation in small animals. Pace LB; Vetter RS J Vet Emerg Crit Care (San Antonio); 2009 Aug; 19(4):329-36. PubMed ID: 25164631 [TBL] [Abstract][Full Text] [Related]
3. [A pathophysiological approach of liver loxoscelism]. Pichardo-Rodriguez R; Saavedra-Velasco M; Grandez-Urbina JA Rev Gastroenterol Peru; 2017; 37(3):287-288. PubMed ID: 29093597 [No Abstract] [Full Text] [Related]
5. Tetracycline protects against dermonecrosis induced by Loxosceles spider venom. Paixão-Cavalcante D; van den Berg CW; Gonçalves-de-Andrade RM; Fernandes-Pedrosa Mde F; Okamoto CK; Tambourgi DV J Invest Dermatol; 2007 Jun; 127(6):1410-8. PubMed ID: 17218940 [TBL] [Abstract][Full Text] [Related]
6. Brown recluse spider venom: proteomic analysis and proposal of a putative mechanism of action. dos Santos LD; Dias NB; Roberto J; Pinto AS; Palma MS Protein Pept Lett; 2009; 16(8):933-43. PubMed ID: 19689420 [TBL] [Abstract][Full Text] [Related]
7. Analysis of therapeutic benefits of antivenin at different time intervals after experimental envenomation in rabbits by venom of the brown spider (Loxosceles intermedia). Pauli I; Minozzo JC; da Silva PH; Chaim OM; Veiga SS Toxicon; 2009 May; 53(6):660-71. PubMed ID: 19673081 [TBL] [Abstract][Full Text] [Related]
8. Seasonality of brown recluse spiders, Loxosceles reclusa, submitted by the general public: implications for physicians regarding loxoscelism diagnoses. Vetter RS Toxicon; 2011 Dec; 58(8):623-5. PubMed ID: 21964630 [TBL] [Abstract][Full Text] [Related]
9. Loxosceles spider venom induces the production of alpha and beta chemokines: implications for the pathogenesis of dermonecrotic arachnidism. Gomez HF; Miller MJ; Desai A; Warren JS Inflammation; 1999 Jun; 23(3):207-15. PubMed ID: 10392755 [TBL] [Abstract][Full Text] [Related]
10. Antigenic and Substrate Preference Differences between Scorpion and Spider Dermonecrotic Toxins, a Comparative Investigation. Ben Yekhlef R; Felicori L; Santos LH; F B Oliveira C; Fadhloun R; Torabi E; Shahbazzadeh D; Pooshang Bagheri K; Salgado Ferreira R; Borchani L Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33019554 [TBL] [Abstract][Full Text] [Related]
11. Cutaneous and systemic effects of varying doses of brown recluse spider venom in a rabbit model. McGlasson DL; Harroff HH; Sutton J; Dick E; Elston DM Clin Lab Sci; 2007; 20(2):99-105. PubMed ID: 17557708 [TBL] [Abstract][Full Text] [Related]
12. Inflammatory mediators generated at the site of inoculation of Loxosceles gaucho spider venom. Barbaro KC; Lira MS; Araújo CA; Pareja-Santos A; Távora BC; Prezotto-Neto JP; Kimura LF; Lima C; Lopes-Ferreira M; Santoro ML Toxicon; 2010 Nov; 56(6):972-9. PubMed ID: 20615425 [TBL] [Abstract][Full Text] [Related]
13. Brown recluse spider envenomation: dermatologic application of hyperbaric oxygen therapy. Tutrone WD; Green KM; Norris T; Weinberg JM; Clarke D J Drugs Dermatol; 2005; 4(4):424-8. PubMed ID: 16004015 [TBL] [Abstract][Full Text] [Related]
14. Characterization of Brown spider (Loxosceles intermedia) hemolymph: cellular and biochemical analyses. Bednaski AV; Trevisan-Silva D; Matsubara FH; Boia-Ferreira M; Olivério MM; Gremski LH; Cavalheiro RP; De Paula DM; Paredes-Gamero EJ; Takahashi HK; Toledo MS; Nader HB; Veiga SS; Chaim OM; Senff-Ribeiro A Toxicon; 2015 May; 98():62-74. PubMed ID: 25720299 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the venom from the Brazilian Brown Spider Loxosceles similis Moenkhaus, 1898 (Araneae, Sicariidae). Silvestre FG; de Castro CS; de Moura JF; Giusta MS; De Maria M; Alvares ES; Lobato FC; Assis RA; Gonçalves LA; Gubert IC; Chávez-Olórtegui C; Kalapothakis E Toxicon; 2005 Dec; 46(8):927-36. PubMed ID: 16289643 [TBL] [Abstract][Full Text] [Related]
17. Brown spiders and loxoscelism. da Silva PH; da Silveira RB; Appel MH; Mangili OC; Gremski W; Veiga SS Toxicon; 2004 Dec; 44(7):693-709. PubMed ID: 15500846 [TBL] [Abstract][Full Text] [Related]
18. Biotechnological applications of brown spider (Loxosceles genus) venom toxins. Senff-Ribeiro A; Henrique da Silva P; Chaim OM; Gremski LH; Paludo KS; Bertoni da Silveira R; Gremski W; Mangili OC; Veiga SS Biotechnol Adv; 2008; 26(3):210-8. PubMed ID: 18207690 [TBL] [Abstract][Full Text] [Related]
19. Phospholipase D from Loxosceles laeta Spider Venom Induces IL-6, IL-8, CXCL1/GRO-α, and CCL2/MCP-1 Production in Human Skin Fibroblasts and Stimulates Monocytes Migration. Rojas JM; Arán-Sekul T; Cortés E; Jaldín R; Ordenes K; Orrego PR; González J; Araya JE; Catalán A Toxins (Basel); 2017 Apr; 9(4):. PubMed ID: 28379166 [TBL] [Abstract][Full Text] [Related]
20. Brown spider dermonecrotic toxin directly induces nephrotoxicity. Chaim OM; Sade YB; da Silveira RB; Toma L; Kalapothakis E; Chávez-Olórtegui C; Mangili OC; Gremski W; von Dietrich CP; Nader HB; Sanches Veiga S Toxicol Appl Pharmacol; 2006 Feb; 211(1):64-77. PubMed ID: 16005484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]